Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Myelodysplastic Syndromes 9Lymphoma, Non-Hodgkin 7Leukemia 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Hematologic Neoplasms 5Congenital Abnormalities 4Breast Neoplasms 4Neuroblastoma 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Wilms Tumor 2Testicular Neoplasms 2Sarcoma 2Rhabdomyosarcoma 2Retinoblastoma 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Medulloblastoma 2Liver Neoplasms 2Kidney Neoplasms 2Hepatoblastoma 2Graft vs Host Disease 2Desmoplastic Small Round Cell Tumor 2Central Nervous System Neoplasms 2Astrocytoma 2

Interventions

Cyclophosphamide 2thymoglobulin 1plerixafor 1fludarabine phosphate 1fludarabine 1aldesleukin 1Thiotepa 1Tacrolimus 1Rituximab 1Mycophenolic Acid 1Melphalan 1Interleukin-2 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cytarabine 1Clofarabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sarcoma, Myeloid × Thiotepa × Clear all
NCT02259348 2017-05-30

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Terminated
12 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡